BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 22124621)

  • 1. A prospective survey of febrile events in hematological malignancies.
    Pagano L; Caira M; Rossi G; Tumbarello M; Fanci R; Garzia MG; Vianelli N; Filardi N; De Fabritiis P; Beltrame A; Musso M; Piccin A; Cuneo A; Cattaneo C; Aloisi T; Riva M; Rossi G; Salvadori U; Brugiatelli M; Sannicolò S; Morselli M; Bonini A; Viale P; Nosari A; Aversa F;
    Ann Hematol; 2012 May; 91(5):767-774. PubMed ID: 22124621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Febrile events in acute lymphoblastic leukemia: a prospective observational multicentric SEIFEM study (SEIFEM-2012/B ALL).
    Di Blasi R; Cattaneo C; Lewis RE; Tumbarello M; Angelici L; Dragonetti G; Busca A; Cambò B; Candoni A; Cesarini M; Cesaro S; Delia M; Fanci R; Farina F; Garzia M; Giordano A; Martino B; Melillo L; Nadali G; Perriello V; Picardi M; Quinto AM; Salutari P; Spolzino A; Vacca A; Vetro C; Zancanella M; Nosari A; Aversa F; Pagano L;
    Ann Hematol; 2018 May; 97(5):791-798. PubMed ID: 29411126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hema e-Chart: Italian Registry for prospective analysis of epidemiology, management and outcome of febrile events in patients with hematological malignancies.
    Pagano L; Caira M; Nosari A; Rossi G; Locatelli F; Viale P; Aversa F;
    J Chemother; 2010 Feb; 22(1):20-4. PubMed ID: 20227988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Etiology of febrile episodes in patients with acute myeloid leukemia: results from the Hema e-Chart Registry.
    Pagano L; Caira M; Nosari A; Rossi G; Viale P; Aversa F; Tumbarello M;
    Arch Intern Med; 2011 Sep; 171(16):1502-3. PubMed ID: 21911638
    [No Abstract]   [Full Text] [Related]  

  • 5. Hema e-Chart registry of invasive fungal infections in haematological patients: improved outcome in recent years in mould infections.
    Nosari AM; Caira M; Pioltelli ML; Fanci R; Bonini A; Cattaneo C; Castagnola C; Capalbo SF; De Fabritiis P; Mettivier V; Morselli M; Pastore D; Aversa F; Rossi G; Pagano L;
    Clin Microbiol Infect; 2013 Aug; 19(8):757-62. PubMed ID: 23279327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procalcitonin: a useful discriminator between febrile conditions of different origin in hemato-oncological patients?
    Schüttrumpf S; Binder L; Hagemann T; Berkovic D; Trümper L; Binder C
    Ann Hematol; 2003 Feb; 82(2):98-103. PubMed ID: 12601488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infections caused by filamentous fungi in patients with hematologic malignancies. A report of 391 cases by GIMEMA Infection Program.
    Pagano L; Girmenia C; Mele L; Ricci P; Tosti ME; Nosari A; Buelli M; Picardi M; Allione B; Corvatta L; D'Antonio D; Montillo M; Melillo L; Chierichini A; Cenacchi A; Tonso A; Cudillo L; Candoni A; Savignano C; Bonini A; Martino P; Del Favero A; ;
    Haematologica; 2001 Aug; 86(8):862-70. PubMed ID: 11522544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of febrile diseases in the emergency department of a Caribbean island: the Curaçao experience.
    Limper M; Gerstenbluth I; Duits AJ; van Gorp EC
    West Indian Med J; 2012 Jan; 61(1):76-80. PubMed ID: 22808570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infection in haematological malignancies.
    Das PK; Chhotaray MK; Rath RN; Kar S; Das B; Parida B
    J Indian Med Assoc; 1994 Oct; 92(10):328-30. PubMed ID: 7822846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of neutropenia for development of invasive infections at various phases of treatment for hemato-oncological diseases in children.
    Zwitserloot AM; Mavinkurve-Groothuis AM; Galama JM; Verweij PE; Hoogerbrugge PM; Warris A
    Scand J Infect Dis; 2012 May; 44(5):355-62. PubMed ID: 22216875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surveillance of infectious complications in hemato-oncological patients.
    Ram R; Gafter-Gvili A; Raanani P; Yeshurun M; Shpilberg O; Dreyer J; Peck A; Leibovici L; Paul M
    Isr Med Assoc J; 2009 Mar; 11(3):133-7. PubMed ID: 19544700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study.
    Pagano L; Caira M; Candoni A; Offidani M; Fianchi L; Martino B; Pastore D; Picardi M; Bonini A; Chierichini A; Fanci R; Caramatti C; Invernizzi R; Mattei D; Mitra ME; Melillo L; Aversa F; Van Lint MT; Falcucci P; Valentini CG; Girmenia C; Nosari A
    Haematologica; 2006 Aug; 91(8):1068-75. PubMed ID: 16885047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One-Year Prospective Study of Community Acquired Influenza and Parainfluenza Viral Infections in Hospitalized Egyptian Children with Malignancy: Single Center Experience.
    Tantawy AA; Barakat MM; Adly AA; Ebeid FS; Shamaa MF; Yassin M
    Pediatr Hematol Oncol; 2015; 32(5):304-14. PubMed ID: 25871509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifungal therapy in patients with hematological malignancies: how to avoid overtreatment?
    Cherif H; Kalin M; Björkholm M
    Eur J Haematol; 2006 Oct; 77(4):288-92. PubMed ID: 16856930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fever of unknown origin in the 21st century: infectious diseases].
    Schneider T; Loddenkemper C; Rudwaleit M; Lode H; Zeitz M
    Dtsch Med Wochenschr; 2005 Nov; 130(47):2708-12. PubMed ID: 16294287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applying the Multinational Association for Supportive Care in Cancer risk scoring in predicting outcome of febrile neutropenia patients in a cohort of patients.
    Baskaran ND; Gan GG; Adeeba K
    Ann Hematol; 2008 Jul; 87(7):563-9. PubMed ID: 18437382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective, randomized study comparing cefepime and imipenem-cilastatin in the empirical treatment of febrile neutropenia in patients treated for haematological malignancies.
    Cherif H; Björkholm M; Engervall P; Johansson P; Ljungman P; Hast R; Kalin M
    Scand J Infect Dis; 2004; 36(8):593-600. PubMed ID: 15370671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and outcome of infections in human immunodeficiency virus/hepatitis C virus-coinfected liver transplant recipients: a FIPSE/GESIDA prospective cohort study.
    Moreno A; Cervera C; Fortún J; Blanes M; Montejo E; Abradelo M; Len O; Rafecas A; Martín-Davila P; Torre-Cisneros J; Salcedo M; Cordero E; Lozano R; Pérez I; Rimola A; Miró JM;
    Liver Transpl; 2012 Jan; 18(1):70-81. PubMed ID: 21898772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics, prognostic factors, and outcomes of adult patients with hemophagocytic lymphohistiocytosis.
    Otrock ZK; Eby CS
    Am J Hematol; 2015 Mar; 90(3):220-4. PubMed ID: 25469675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluoroquinolone resistance in hematopoietic stem cell transplant recipients with infectious complications.
    Bonadio M; Morelli G; Mori S; Riccioni R; Papineschi F; Petrini M
    Biomed Pharmacother; 2005 Oct; 59(9):511-6. PubMed ID: 16274955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.